Transcriptomics

Dataset Information

0

The CaSm (LSm1) oncogene promotes transformation, chemoresistance, and metastasis of pancreatic cancer cells


ABSTRACT: The Cancer associated Sm-like (CaSm) oncogene is overexpressed in 87% of human pancreatic tumor samples and CaSm knockdown has demonstrated therapeutic efficacy in murine models of pancreatic cancer. Evidence indicates that CaSm modulates mRNA degradation; however, its target genes and the mechanisms by which CaSm promotes pancreatic cancer remain largely unknown. Here, we demonstrate that the CaSm overexpression alters several hallmarks of cancer – including transformation, proliferation, chemoresistance, and metastasis. Doxycycline-induced CaSm expression enhanced proliferation and both anchorage-dependent and -independent growth of the human Panc-1 cells in vitro. CaSm induction decreased gemcitabine-induced cytotoxicity and altered the expression of apoptotic regulation genes, including Bad, E2F1, and Bcl-XL. CaSm-overexpressing Panc-1 cells were 2-fold more migratory and 4-fold more invasive than the driver controls and demonstrated characteristics of epithelial-to-mesenchymal transition such as morphological changes and decreased E-cadherin expression. CaSm induction resulted in changes in RNA expression of metastasis-associated genes such as MMP1, SerpinB5, uPAR, and Slug. Using a murine model of metastatic pancreatic cancer, injection of CaSm-induced Panc-1 cells resulted in a higher abundance of hepatic metastatic lesions. Overall, CaSm overexpression contributed to a more aggressive cancer phenotype in Panc-1 cells, further supporting the use of CaSm as a therapeutic target against pancreatic cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE74319 | GEO | 2015/10/24

SECONDARY ACCESSION(S): PRJNA299658

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-10-24 | E-GEOD-74319 | biostudies-arrayexpress
2010-09-03 | E-GEOD-23952 | biostudies-arrayexpress
2020-04-16 | GSE148439 | GEO
2021-08-11 | GSE149103 | GEO
2020-12-11 | GSE162981 | GEO
2019-07-07 | GSE110580 | GEO
2010-09-03 | GSE23952 | GEO
2024-09-02 | BIOMD0000000926 | BioModels
2022-01-01 | GSE166799 | GEO
2023-09-19 | PXD042256 | Pride